SWOT Analysis for Link Pharma Chem Ltd.

Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Companies with Zero Promoter Pledge
Stock with Low PE (PE < = 10)

Red Flag: High Interest Payments Compared to Earnings
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Book Value Per Share deteriorating for last 2 years
Fall in Quarterly Revenue and Net Profit (YoY)
Increasing Trend in Non-Core Income
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter

Rising Delivery Percentage Compared to Prev Day
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Link Pharma Chem Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats